Acediur

Quick links to important sections

Acediur

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acediur

Property Description
Active ingredient Captopril, Hydrochlorothiazide
Form Oral tablet (Fixed-dose combination)
Pharmacological class ACE Inhibitor and Thiazide Diuretic
Common use Management of high blood pressure (Hypertension)
Origin Synthetic chemical compounds

Acediur is a prescription-only medicine primarily classified as an antihypertensive agent used for managing high blood pressure (hypertension). It is a fixed-dose combination product, meaning it contains two distinct active substances in a single oral tablet dosage form. The drug belongs to the pharmacological class of agents that modify the renin-angiotensin system, combining an Angiotensin-Converting Enzyme (ACE) inhibitor with a thiazide diuretic. This combination formulation is designed to provide a dual approach to treatment.


What Are the Active Components of Acediur?

The essential composition of Acediur includes the two synthetic active ingredients, Captopril and Hydrochlorothiazide. Captopril is the ACE inhibitor component, which works to interrupt the enzymatic pathway that controls vascular tension, while Hydrochlorothiazide serves as the diuretic, or "water pill." The combination of these two agents in a fixed dose is often deployed when a patient's high blood pressure is not adequately controlled by a single medication. These components are utilized for their respective roles in treating cardiovascular conditions. This dual-ingredient tablet is designed to ensure a synergistic effect, where the combined action achieves a more potent and stable reduction in blood pressure than either compound used as a monotherapy.


What Is the General Purpose of This Combination Drug?

  1. The general purpose of Acediur is to achieve effective and sustained antihypertensive activity by targeting two different physiological causes of high blood pressure simultaneously. The combination facilitates a dual approach: one component promotes the relaxation and widening of blood vessels, and the other encourages the removal of excess salt and fluid from the body through diuresis. This action works to significantly decrease the strain on the arteries and reduce the load on the heart, providing comprehensive control necessary for the long-term management of essential hypertension.

Regulatory References

  1. WHO Essential Medicines List

What side effects are possible with Acediur?

Acediur's safety profile is defined by both common adverse reactions and certain serious risks requiring strict regulatory warnings and patient monitoring. The most frequently reported adverse events are typically common and include cough, dizziness, fatigue, and gastrointestinal symptoms such as nausea.

Serious and Clinically Significant Adverse Reactions

Regulatory documents highlight several serious and clinically significant risks:

  • Angioedema: Rapid swelling of the face, lips, tongue, and/or throat, which may cause difficulty breathing or swallowing. This reaction warrants immediate medical attention.
  • Acute Hepatic Injury: Cases of symptomatic liver injury and elevations in liver enzymes have been reported, requiring regular monitoring of liver function.
  • Hypotension: A decrease in blood pressure, particularly in patients with pre-existing volume depletion (e.g., from diuretics, vomiting, or diarrhea), requiring caution and possible dose adjustment.
  • Severe Diarrhea: This is a key safety limitation, especially in older patients.

Safety Restrictions and Monitoring

Acediur is contraindicated and must not be used in the following circumstances:

  • Pregnancy: Use during pregnancy is associated with risks of fetal injury or death, particularly during the second and third trimesters.
  • History of Angioedema: Due to increased risk of recurrence.
  • Severe Renal Impairment or Anuria.
  • Concomitant use with Aliskiren in patients with diabetes or renal impairment.

Close safety monitoring by a healthcare professional is mandatory, focusing on renal function (creatinine and blood urea levels) and serum electrolyte levels (e.g., potassium), as imbalances may occur.

Overdose and Emergency Response

The overdose profile for Acediur (Captopril/Hydrochlorothiazide) is defined by the severe physiological consequences resulting from the combined effects of the active components, as documented in regulatory labeling.

Overdose scope Regulatory Description
Documented overdose presentations: The primary manifestation is Profound Hypotension, often accompanied by Syncope (fainting) or severe Drowsiness leading potentially to Coma. Other signs include severe Fluid and Electrolyte Derangement (Hyponatremia, Hyperkalemia), Oliguria (reduced urine output), and Gastrointestinal disturbances (Nausea, Vomiting).
Physiological systems affected: Cardiovascular System (Hypotension, Tachycardia), Renal System (Acute Renal Failure), Central Nervous System (CNS Depression, Seizures), and Fluid/Electrolyte Balance.
When immediate medical help is required: The official guidance mandates calling emergency services (911) immediately if the individual has collapsed, is having a seizure, is having trouble breathing, or cannot be awakened. Immediate medical attention is required for suspected overdose or the development of Angioedema.
Overdose classifications (high-level) Regulatory Description
Severity classification: Overdose involves Severe and potentially Life-Threatening outcomes, including fatal Angioedema and Acute Renal Failure.
Overdose-context constraints: No specific antidote is known; management focuses on Symptomatic and Supportive Treatment, primarily volume repletion (IV fluids) and monitoring of vital signs for up to 24 hours.

Connection to the overall overdose profile: Regulatory documents define the overdose profile by detailing the severe physiological consequences resulting from the combined effects of the active components. This framework establishes clear, non-negotiable triggers for when urgent medical help must be sought, emphasizing the need for immediate intervention to manage life-threatening outcomes like airway compromise or acute organ damage.

Therapeutic Uses of Acediur

What Acediur Treats: Main Uses and Benefits

Acediur is a prescription medication primarily used for the long-term, sustained management of high blood pressure (hypertension). It is a strategic therapy, focusing on controlling the chronic, underlying condition and the associated systemic imbalance, as hypertension is often a silent or asymptomatic presentation.


Therapeutic Role and Patient Benefit

Acediur is commonly used in clinical scenarios for essential hypertension and specifically when the condition is uncontrolled by a single blood pressure medication. The dual-agent approach helps address the complex nature of the condition, supporting a therapeutic optimization that is often appropriate for achieving and maintaining target blood pressure levels. The primary goal is to manage the long-term systemic burden, which means the medication may be part of symptomatic management for conditions associated with heightened physiological stress.

Quick Fact: Support for Systemic Imbalance


The medication contributes to easing the overall symptom load by actively supporting systemic balance. This sustained action may assist with maintaining functional stability and helps reduce the chance of developing related, long-term complications, supporting the health of organs such as the kidneys.

Eligibility and Restrictions for Use

Acediur is a combination medication containing enalapril (an ACE inhibitor) and hydrochlorothiazide (a diuretic), primarily used to treat high blood pressure (hypertension).


Who Can Use Acediur?

This medication is typically prescribed for adult patients who require combined therapy for their hypertension. It is often used when a patient's blood pressure is not adequately controlled by either enalapril or hydrochlorothiazide alone.


Who Cannot Use Acediur (Contraindications)?

Acediur should not be used by people with certain medical conditions due to the risk of serious adverse effects. Contraindications include:

Condition Reason for Restriction
Pregnancy (especially in the second and third trimesters) Significant risk of harm and death to the unborn baby.
History of Angioedema Increased risk of severe allergic reaction (swelling of the face, lips, tongue, or throat).
Anuria (Inability to produce urine) Due to the hydrochlorothiazide component.
Known Allergy To enalapril, hydrochlorothiazide, other ACE inhibitors, or sulfonamide-derived drugs.
Severe Kidney or Liver Impairment May worsen these conditions.

It is also generally avoided in patients with diabetes or renal impairment who are taking medications containing aliskiren, or within 36 hours of taking a medicine containing sacubitril.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Acediur, a combination of Hydrochlorothiazide and Amiloride, has a documented interaction profile primarily centered on its effects on potassium levels and blood pressure.

Contraindicated Combinations

Co-administration with potassium supplements and other potassium-sparing agents (such as spironolactone or triamterene) is strictly restricted by regulatory documents due to a high risk of severe hyperkalemia (elevated serum potassium). In certain official formularies, use with Dofetilide or Cidofovir may also be restricted.


Significant Interaction Classes

Interacting Product Category Regulatory Concern Example Agent
Potassium-Modifying Agents Risk of Hyperkalemia Potassium supplements
Antihypertensives Potentiation of Hypotension ACE Inhibitors, ARBs
Renal Clearance Reducers Increased Toxicity Risk Lithium
Diuretic Efficacy Reducers Diminished Therapeutic Effect NSAIDs

Specific Interaction Constraints

Concomitant use with Angiotensin-Converting Enzyme (ACE) Inhibitors or Angiotensin II Receptor Blockers (ARBs) may increase the risk of hyperkalemia and severe blood pressure reduction. The drug also reduces the renal clearance of Lithium, which can lead to dangerously high lithium levels. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) can diminish the intended natriuretic and blood pressure-lowering effects of the medication. The official product information specifies that the medication should be discontinued three days before any planned glucose tolerance testing.

Mechanism of Action

Dual Modulation of Vascular Resistance

The mechanism of action of Acediur centers on modulating key pathways involved in vascular regulation to produce a systemic physiological effect. The mechanism focuses on modulating vascular resistance, which is distinct from pathways primarily involving fluid balance or hormonal systems. Acediur engages two core mechanistic domains that govern blood vessel diameter. It acts as an antagonist at specific Alpha-1 adrenergic receptors ( A1a) to interrupt the vasoconstrictive signaling from the sympathetic nervous system.

Concurrently, Acediur blocks L-type Ca^2+ channels in the vascular smooth muscle. This dual engagement modifies early molecular steps that shape systemic physiological outcomes, leading to muscle relaxation and widening of the arteries.

Cascade to Reduced Systemic Load

These targeted molecular actions initiate a cascade that results in a reduction in total peripheral resistance (TPR). By limiting both the neurogenic (Alpha-1) and intrinsic (calcium-mediated) factors driving vessel constriction, Acediur promotes vasodilation. This process limits the effects of elevated vascular resistance, promoting a change in vascular resistance, which results in the mechanistic consequence of lowering arterial blood pressure.

Dosage and Administration Information

The administration of Acediur follows established protocols for intake, dosage, and adjustment intervals. As a fixed-dose oral tablet, the route is restricted to oral administration only. This protocol ensures adherence to a sustained, long-term management plan.


Administration Guidelines

Instruction Detail
Route and Form Administered exclusively as an oral tablet.
Dosing Schedule The typical initial adult dosage is 25 mg Captopril / 15 mg Hydrochlorothiazide once daily. The total daily dosage must not exceed the equivalent of 150 mg Captopril / 50 mg Hydrochlorothiazide.
Timing in relation to meals The tablet must be taken one hour before a meal. This procedural instruction is in place because the presence of food in the stomach can reduce the absorption of the Captopril component.
Frequency Pattern The primary administration schedule is once daily, though the regimen may include administration in two divided doses per day for maintenance.
Population Adjustments Use of the fixed combination is generally not recommended for patients with severe renal impairment (Creatinine Clearance < 30 mL/min). A lower starting dose may also be prescribed for older adults or those with volume depletion.

Procedural Use Protocol

The administration of this medication is structured as long-term, sustained therapy and requires adherence to a specific titration interval. Dose adjustments, or changes to the prescribed strength, should only be made after waiting approximately six to eight weeks. This defined waiting period ensures the full therapeutic effect of the current dose is established before any further modification to the regimen is considered. The entire administration protocol emphasizes consistency and adherence to the defined dosing schedule.

Recent Clinical Evidence

Acediur is a combination medication containing amiloride hydrochloride (a potassium-spsparing diuretic) and hydrochlorothiazide (a thiazide diuretic). Clinical evidence for the fixed-dose combination has largely focused on its efficacy and safety profile in managing essential hypertension (high blood pressure) and edema (fluid retention), often associated with congestive heart failure.

Efficacy in Hypertension

Clinical trials have consistently shown that the combination of hydrochlorothiazide and amiloride is an effective treatment for lowering blood pressure. Studies comparing the combination to hydrochlorothiazide alone in patients with essential hypertension demonstrated equivalent blood pressure reduction between the two regimens. This suggests that the inclusion of amiloride does not compromise the antihypertensive effect of the thiazide component.

Impact on Electrolyte Balance

One of the primary benefits highlighted in the clinical data is the combination’s favorable impact on serum potassium levels. Thiazide diuretics, when used alone, can lead to hypokalemia (low potassium levels). Randomized controlled trials have shown that the addition of the potassium-sparing diuretic amiloride significantly reduces the incidence of hypokalemia compared to hydrochlorothiazide monotherapy. Maintaining potassium balance is an important factor in reducing the risk of associated cardiovascular complications, particularly in vulnerable patient populations.

Long-Term Cardiovascular Outcomes

Long-term studies on diuretic-based regimens, including combinations with a potassium-sparing component, have confirmed their role in reducing the risk of major cardiovascular events. Specifically, the combination of hydrochlorothiazide and amiloride has been shown to reduce the risk for stroke, coronary events, and overall cardiovascular events in hypertensive older adults, underscoring the long-term clinical utility of this therapeutic approach.

Key Studies & References NICE Guideline NG108: Chronic heart failure in adults: diagnosis and management

Frequently Asked Questions (FAQ)

Common questions about Acediur (FAQ)

Q: How quickly should I expect Acediur to start working?

A: The official product information states that the fluid removal effect (diuresis) generally begins quickly after administration. However, the full, sustained blood pressure-lowering effect may require consistent use over several weeks to be fully established.


Q: If I miss taking Acediur, what happens?

A: Regulatory guidelines describe the general protocol as skipping the missed dose and returning to the regular schedule to avoid potential risk from taking two doses too close together.


Q: Does Acediur cause weight loss, or is that just fluid loss?

A: The medication is a diuretic, meaning its primary function is the removal of excess fluid and salt from the body. Therefore, any change in body weight is mainly attributed to this fluid loss, which is the intended therapeutic effect.


Q: Are there any foods or drinks I should avoid while taking Acediur?

A: Official documents describe the need to limit or restrict potassium-rich foods or salt substitutes containing potassium, as Acediur can affect serum potassium levels.


Q: How long does the effect of one dose of Acediur usually last?

A: According to official product information, the duration of the diuretic effect is consistent with the drug’s intended use. The effect typically lasts long enough to support the recommended once-daily administration schedule for sustained management.


Q: Does taking Acediur at night affect sleep?

A: While direct sleeplessness is not always listed as a common effect, the regulatory context suggests caution regarding the timing of diuretics to minimize the potential for increased nighttime urination.


Q: Do older adults typically respond differently to Acediur than younger adults?

A: Regulatory documents indicate that older adult patients may require special consideration. This can include prescribing a lower initial dosage, and official warnings highlight a specific safety limitation (severe diarrhea) that is particularly relevant for this population.


Q: Is Acediur suitable for people with diabetes?

A: A specific regulatory warning restricts the use of Acediur in patients with diabetes or renal impairment who are currently taking medications that contain aliskiren. This is due to an increased risk of serious adverse effects when these medicines are combined.


Q: Are there any specific safety warnings for people taking Acediur with liver issues?

A: Official documents state that the medication is strictly contraindicated for individuals with severe liver impairment. Additionally, warnings exist regarding the risk of acute hepatic injury, and monitoring of liver function is described as necessary due to this risk.


Q: What happens if I stop taking Acediur suddenly?

A: Regulatory documents define that stopping the medication abruptly is not generally supported. All changes to the long-term regimen are defined as being made under the supervision of a healthcare professional.


Q: Can I take Acediur if I am also taking vitamins or mineral supplements?

A: Official documentation addresses specific interactions with supplements. It explicitly restricts co-administration with potassium supplements due to the significant risk of dangerously high potassium levels in the blood.


Q: What does 'contraindicated' mean in the context of Acediur?

A: The term 'contraindicated' is used in regulatory documents to mean that the medication should not be used in certain specific circumstances or conditions. This is because the potential risk of serious harm in those situations outweighs any possible benefit.


Q: How does Acediur relate to medicines for heart conditions?

A: Acediur is a drug prescribed for the management of high blood pressure (hypertension). It is also indicated for fluid retention (edema) that is often associated with conditions such as congestive heart failure.


Q: Does Acediur cause dryness or dehydration?

A: The medication functions as a diuretic, increasing fluid output. Regulatory documents include warnings about potential fluid and electrolyte imbalances that can occur. These imbalances may be associated with symptoms like dehydration or excessive dryness.


Q: Is Acediur safe to use during pregnancy or breastfeeding?

A: Use during pregnancy is strictly contraindicated, particularly in the second and third trimesters, due to the significant risk of harm to the unborn baby. For breastfeeding, the active ingredients pass into breast milk, and official documents define that use during this time is generally not supported.


Q: Why do some people take Acediur in the morning instead of the evening?

A: The official administration schedule specifies once-daily dosing. Because Acediur has a diuretic effect that encourages the removal of fluid, a typical medical practice is to take the dose in the morning to minimize the potential for increased nighttime urination.


Q: What are the rules regarding driving or operating machinery while on Acediur?

A: Caution is noted in regulatory documents regarding driving or operating machinery because the medication may cause dizziness, fatigue, or lightheadedness.


Q: Can Acediur be crushed or split if someone has trouble swallowing pills?

A: Official product information defines that fixed-dose combination tablets are generally not permitted to be crushed or split unless specific, scored instructions are provided on the tablet label.


Q: Does Acediur have any known effect on cholesterol levels?

A: Regulatory documents sometimes note the drug’s potential effect on metabolic markers. Official reports have indicated that minor, temporary elevations in certain markers, including cholesterol or triglycerides, may be observed in some patients.


Q: Is Acediur known to affect mood or cause sleeplessness?

A: Official regulatory lists of adverse events mention certain central nervous system (CNS) effects. While uncommon, these effects could potentially influence a patient's mood or overall sleep patterns.


Q: Can Acediur interact with alcoholic beverages?

A: Official documents state that alcohol may increase or enhance the blood pressure-lowering effect of Acediur. This interaction could potentially increase the risk of experiencing adverse effects such as lightheadedness or dizziness.


Q: Is it normal to have a slight change in appetite when taking Acediur?

A: Regulatory lists of common side effects include certain gastrointestinal (stomach and bowel) effects. These specific effects may indirectly lead to a reported slight change in a patient's appetite.


Q: What information is available about Acediur and pediatric use?

A: According to official regulatory documents, the safety and effectiveness of Acediur have generally not been established for use in pediatric patients. This means the medication is typically restricted to adults (18 years of age and older).


Q: What are the main risks associated with taking too much Acediur?

A: Official safety information regarding taking too much medication describes primary risks. These include marked hypotension, which is severely low blood pressure, and potential disturbances in fluid and electrolyte balance in the body.


Q: Is Acediur used for conditions other than high blood pressure or swelling?

A: The drug is officially indicated only for the management of high blood pressure (essential hypertension) and for fluid retention (edema) associated with congestive heart failure. Regulatory documents define its approved uses specifically to these conditions.


Q: Can Acediur cause sensitivity to sunlight?

A: Regulatory information notes a specific safety risk associated with the medication's composition. The hydrochlorothiazide component is known to cause a reaction called photosensitivity, which can make the skin more sensitive to sun exposure.

How should Acediur be stored and disposed of?

Storage and Disposal of Acediur

Item Official Regulatory Requirement
Storage Temperature Store at Controlled Room Temperature between 20 C and 25 C (68 F and 77 F), permitting brief excursions to 15 C to 30 C (59 F to 86 F).
Protection Requirements The container must be kept tightly closed and the medicine must be protected from moisture and kept from freezing.
Child Safety Must be kept out of the reach and sight of children.
Disposal Disposal should follow local regulations. The preferred method is a drug take-back program. Do not flush down a toilet or drain.

Official labeling defines that the product must be maintained within the specified temperature range, with freezing strictly prohibited. Container integrity is mandatory to protect against moisture. For disposal, the instructions direct users to consult a healthcare professional and prioritize authorized take-back options, while explicitly advising against flushing.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Acediur found in:

A-Z Index: